Image de couverture de livre

A phase 1 evaluation of inhaled oxytocin: Physiologically‐based pharmacokinetic model informed dosing of a novel heat‐stable oxytocin delivery system

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Pete Lambert, Carl M. J. Kirkpatrick, Rory Marriott, Siladitya Ray Chaudhuri, David Polidori, Bart Remmerie, Michelle P. McIntosh
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	British Journal of Clinical Pharmacology
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Application of immunocapture and nanoflow LC–MS/MS to overcome the barriers to the quantitation of oxytocin in plasma of women in third stage labour
par: Sebastiaan Bijttebier, et autres
Publié: (2024)

Physiologically based pharmacokinetic modelling of cefoperazone in paediatrics
par: Qiushi Wang, et autres
Publié: (2024)

Physiologically based pharmacokinetic modelling predicts altered maternal pharmacokinetics of amitriptyline during pregnancy
par: Maike Scherf‐Clavel, et autres
Publié: (2025)

High‐dose methotrexate pharmacokinetics and its impact on prognosis of paediatric acute lymphoblastic leukaemia patients: A population pharmacokinetic study
par: Xiaoxiao Chen, et autres
Publié: (2024)

Population pharmacokinetics and optimized dosing of cefuroxime in critically ill patients
par: Jaap W. A. Mouton, et autres
Publié: (2025)

Physiologically based pharmacokinetic model for oxcarbazepine active metabolite to predict pharmacokinetics in paediatric patients with renal impairment and adjust dosages
par: Cheng‐jie Ke, et autres
Publié: (2025)

Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy
par: Shakir Atoyebi, et autres
Publié: (2024)

Single‐dose pharmacokinetics and safety of ACC017, a novel HIV integrase inhibitor, in healthy adult participants: A first‐in‐human study
par: C. Hu, et autres
Publié: (2025)

Safety, tolerability and pharmacokinetics of DNDI‐6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants
par: Jean‐Yves Gillon, et autres
Publié: (2025)

Pharmacokinetics of vancomycin in sputum of intubated patients: Optimized intravenous delivery vs. inhaled therapy
par: Lucy B. Palmer, et autres
Publié: (2024)

Population pharmacokinetics and dosing of dispersible moxifloxacin formulation in children with rifampicin‐resistant tuberculosis
par: Megan Palmer, et autres
Publié: (2025)

Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
par: Clifford G. Banda, et autres
Publié: (2024)

Population pharmacokinetics of TBAJ‐587 and its main metabolites—Evaluation of different loading dose strategies and early dose selection
par: Albin A. M. Leding, et autres
Publié: (2025)

Correction to “Recommended approaches for integration of population pharmacokinetic modelling with precision dosing in clinical practice”
Publié: (2025)

Model‐informed vancomycin precision dosing by population pharmacokinetics combined with machine learning algorithms
par: Lei Shi, et autres
Publié: (2026)

Physiologically‐based pharmacokinetic modelling of uridine 5′‐diphosphoglucorosultransferase (UGT) substrate drugs in pregnant women
par: William Saffaf, et autres
Publié: (2026)

The feasibility of pharmacokinetic‐based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trial
par: Alexandra Power‐Hays, et autres
Publié: (2025)

Single‐ascending dose and food effect studies to assess safety and pharmacokinetics of ainuovirine, a novel non‐nucleoside reverse transcriptase inhibitor, for treatment of HIV‐1 infection
Publié: (2024)

Systematic review and scoring‐based selection of pharmacokinetic models for precision dosing of vancomycin in neonates and children
par: Zoë Vander Elst, et autres
Publié: (2026)

Population pharmacokinetics of high‐dose methotrexate and 7‐hydroxy methotrexate in Chinese adults with primary central nervous system lymphoma
par: Ruoyun Wu, et autres
Publié: (2025)

Design of a pharmacokinetic/pharmacodynamic model for administration of low dose peripheral norepinephrine during general anaesthesia
par: Jona Joachim, et autres
Publié: (2024)

Development of a novel tyrosine kinase 2 inhibitor ARTS‐011 and its first‐in‐human single and multiple ascending dose Phase I study to evaluate the tolerability, safety, pharmacokinetic profile and food effects
par: Zhili Jin, et autres
Publié: (2026)

Physiologically based pharmacokinetic model combined with a clinical lactation study to determine doravirine concentrations in human breastmilk
par: Lena van der Wekken‐Pas, et autres
Publié: (2025)

Preclinical pharmacokinetics of novel long‐acting tenofovir alafenamide/bictegravir solid injectable in rats
Publié: (2024)

A simulation study to assess the influence of population pharmacokinetic model selection on initial dosing recommendations of vancomycin in neonates
par: Mehdi El Hassani, et autres
Publié: (2024)

Population pharmacokinetics of ABC/DTG/3TC FDC to support dosing in PEDS with HIV‐1 (IMPAACT 2019)
Publié: (2024)

Physiologically based pharmacokinetic modelling of the co‐administration of ritonavir‐boosted atazanavir and rifampicin in children co‐treated for HIV and TB
Publié: (2024)

JAK–STAT inhibitory effect of IN‐115314, a novel small molecule inhibitor, and pharmacokinetic/pharmacodynamic study in canine
par: Jae‐Hun Ahn, et autres
Publié: (2025)

Development of a population pharmacokinetic model for the novel long‐acting injectable antipsychotic risperidone ISM®
par: Christian Laveille, et autres
Publié: (2024)

Safety, pharmacokinetics and pharmacodynamics of NXC736, a novel sphingosine‐1‐phosphate receptor modulator
par: Woo Kyung Chung, et autres
Publié: (2026)

Hair analysis of formoterol as a novel tool to assess long‐term inhalation medication adherence: Data from the TRICOLON trial
par: Liz J. A. Cuperus, et autres
Publié: (2026)

Administration mode matters for 5‐fluorouracil therapy: Physiologically based pharmacokinetic evidence for avoidance of myelotoxicity by continuous infusion but not intravenous bolus
par: Chih‐Jia Chao, et autres
Publié: (2024)

Single‐dose and steady‐state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug–drug interaction study
par: Amelie Leutzendorff, et autres
Publié: (2024)

Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney‐transplanted patients
par: Katrine Agergaard, et autres
Publié: (2024)

Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment
par: Shibeilei Lin, et autres
Publié: (2025)

Effect of food on pharmacokinetics of ACC017, a novel HIV‐1 integrase inhibitor, in healthy adult subjects
par: C. Hu, et autres
Publié: (2025)

Safety, tolerability, pharmacokinetics and pharmacodynamics of HSK31858, a novel oral dipeptidyl peptidase‐1 inhibitor, in healthy volunteers: An integrated phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose study
par: Yuhao Wang, et autres
Publié: (2025)

Early clinical pharmacology evaluation of the novel anti‐inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions
par: Dave Singh, et autres
Publié: (2026)

Physiologically based pharmacokinetic integrated models for lamotrigine to evaluate drug exposure and optimize dosage during pregnancy, foetal period, postpartum period, and in breastfed neonates
par: Zhiwei Liu, et autres
Publié: (2025)

A prospective study evaluating the safety and pharmacokinetics of ponatinib at a fixed dose in six paediatric patients with philadelphia chromosome‐positive leukaemia: JCCG PedPona19 study
par: Yuichi Kodama, et autres
Publié: (2025)